From: Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation
Characteristics | Value |
---|---|
Patients | 616 |
Pre-TACE | 145 (23.5) |
Age (yrs.) | 56.0 (18.0) |
Male | 556 (90.3) |
Ablation | |
 Radiofrequency | 469 (76.1) |
 Microwave | 147 (23.9) |
Tumor number | |
 Single | 499 (81.0) |
 Multiple | 117 (19.0) |
Tumor size (cm) | |
 ≤ 3 | 473 (76.8) |
 > 3 | 143 (23.2) |
Risk area | 159 (25.8) |
AFP ≥200 ng/ml | 187 (30.4) |
Hb (109/L) | 142.0 (22.3) |
PLT (109/L) | 121.0 (90.0) |
RBC (109/L) | 4.6 (0.8) |
WBC (109/L) | 5.2 (2.5) |
ALB (g/L) | 41.5 (6.0) |
ALT (U/L) | 35.2 (26.8) |
AST (U/L) | 33.6 22.57) |
TBIL (μmol/L) | 15.0 (20.4) |
Child-Pugh grade | |
 A | 594 (96.4) |
 B | 22 (3.6) |
PT (seconds) | 12.3 (1.8) |
Viral hepatitis | 574 (93.2) |
Cirrhosis | 503 (81.7) |